157 related articles for article (PubMed ID: 38613793)
1. NXPH4 can be used as a biomarker for pan-cancer and promotes colon cancer progression.
Zhang Z; Wang P; Chen S; Xiang D; Chen J; Huang W; Liu X; Yi T; Wang D; Pu Y; He L; Zhang H
Aging (Albany NY); 2024 Apr; 16(7):5866-5886. PubMed ID: 38613793
[TBL] [Abstract][Full Text] [Related]
2. Neurexophilin 4 is a prognostic biomarker correlated with immune infiltration in bladder cancer.
Sun X; Xin S; Jin L; Zhang Y; Ye L
Bioengineered; 2022 May; 13(5):13986-13999. PubMed ID: 35758021
[TBL] [Abstract][Full Text] [Related]
3. High expression of NXPH4 correlates with poor prognosis, metabolic reprogramming, and immune infiltration in colon adenocarcinoma.
Sun Z; Wang H; Xu Y; Liu Y; Wang L; Zhou R; Zhou R; Ma W; Zhang T
J Gastrointest Oncol; 2024 Apr; 15(2):641-667. PubMed ID: 38756632
[TBL] [Abstract][Full Text] [Related]
4. Increased Expression of NXPH4 Correlates with Immune Cell Infiltration and Unfavorable Prognosis in Hepatocellular Carcinoma.
Tang Q; Chen YM; Shen MM; Dai W; Liang H; Liu JN; Gao J
J Oncol; 2022; 2022():5005747. PubMed ID: 36245978
[TBL] [Abstract][Full Text] [Related]
5. Autophagy-related CMTM6 promotes glioblastoma progression by activating Wnt/β-catenin pathway and acts as an onco-immunological biomarker.
Dai L; Xiao J; Li X; Tao Y; Zhou P; Lyu L; Shi Z; Liang X; Jia Z; Jiang S
J Gene Med; 2024 May; 26(5):e3685. PubMed ID: 38686653
[TBL] [Abstract][Full Text] [Related]
6. miRNA-185 serves as a prognostic factor and suppresses migration and invasion through Wnt1 in colon cancer.
Zhang W; Sun Z; Su L; Wang F; Jiang Y; Yu D; Zhang F; Sun Z; Liang W
Eur J Pharmacol; 2018 Apr; 825():75-84. PubMed ID: 29454608
[TBL] [Abstract][Full Text] [Related]
7. Study on effects of miR-141-3p in proliferation, migration, invasion and apoptosis of colon cancer cells by inhibiting Bcl2.
Tong SJ; Zhang XY; Guo HF; Yang J; Qi YP; Lu S
Clin Transl Oncol; 2021 Dec; 23(12):2526-2535. PubMed ID: 34086253
[TBL] [Abstract][Full Text] [Related]
8. Deoxyribonuclease 1-like 3 may be a potential prognostic biomarker associated with immune infiltration in colon cancer.
Liu J; Yi J; Zhang Z; Cao D; Li L; Yao Y
Aging (Albany NY); 2021 Jun; 13(12):16513-16526. PubMed ID: 34157681
[TBL] [Abstract][Full Text] [Related]
9. miR‑205 suppresses cell migration, invasion and EMT of colon cancer by targeting mouse double minute 4.
Fan Y; Wang K
Mol Med Rep; 2020 Aug; 22(2):633-642. PubMed ID: 32467998
[TBL] [Abstract][Full Text] [Related]
10. NXPH4 Promotes Gemcitabine Resistance in Bladder Cancer by Enhancing Reactive Oxygen Species and Glycolysis Activation through Modulating NDUFA4L2.
Wang D; Zhang P; Liu Z; Xing' Y; Xiao Y
Cancers (Basel); 2022 Aug; 14(15):. PubMed ID: 35954445
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive pan-cancer analysis reveals NUSAP1 is a novel predictive biomarker for prognosis and immunotherapy response.
Zheng H; Wang M; Zhang S; Hu D; Yang Q; Chen M; Zhang X; Zhang Y; Dai J; Liou YC
Int J Biol Sci; 2023; 19(14):4689-4708. PubMed ID: 37781040
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone inhibits hypoxia-induced epithelial-mesenchymal transition in colon cancer.
Kim JH; Hwang YJ; Han SH; Lee YE; Kim S; Kim YJ; Cho JH; Kwon KA; Kim JH; Kim SH
World J Gastroenterol; 2015 Sep; 21(34):9887-99. PubMed ID: 26379394
[TBL] [Abstract][Full Text] [Related]
13. Egr‑1 inhibits colon cancer cell proliferation, migration and invasion via regulating CDKL1 at the transcriptional level.
Shao S; Ju M; Lei J; Lu X; Li H; Wang D; Xia C
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34165179
[TBL] [Abstract][Full Text] [Related]
14. miR-152-3p Affects the Progression of Colon Cancer via the KLF4/IFITM3 Axis.
Zhu X; Shen Z; Man D; Ruan H; Huang S
Comput Math Methods Med; 2020; 2020():8209504. PubMed ID: 32952601
[TBL] [Abstract][Full Text] [Related]
15. ITGBL1 promotes migration, invasion and predicts a poor prognosis in colorectal cancer.
Qiu X; Feng JR; Qiu J; Liu L; Xie Y; Zhang YP; Liu J; Zhao Q
Biomed Pharmacother; 2018 Aug; 104():172-180. PubMed ID: 29772438
[TBL] [Abstract][Full Text] [Related]
16. Forkhead box protein K1‑regulated neurexophilin 4 promotes proliferation, metastasis and glycolysis in colorectal cancer.
Fan Q; He W; Shang Y
Exp Ther Med; 2023 Sep; 26(3):434. PubMed ID: 37602314
[TBL] [Abstract][Full Text] [Related]
17. miR-20b-5p functions as tumor suppressor microRNA by targeting cyclinD1 in colon cancer.
Yang H; Lin J; Jiang J; Ji J; Wang C; Zhang J
Cell Cycle; 2020 Nov; 19(21):2939-2954. PubMed ID: 33044899
[TBL] [Abstract][Full Text] [Related]
18. HIG1 domain family member 1A disrupts proliferation, migration, and invasion of colon adenocarcinoma cells.
Xu Z; Sun J; Mao Y; Chen Y; Zhang T; Qin Y; Hua D
Bioengineered; 2021 Dec; 12(2):10501-10511. PubMed ID: 34787061
[TBL] [Abstract][Full Text] [Related]
19. Numb inhibits migration and promotes proliferation of colon cancer cells via RhoA/ROCK signaling pathway repression.
Yang Y; Li L; He H; Shi M; He L; Liang S; Qi J; Chen W
Exp Cell Res; 2022 Feb; 411(2):113004. PubMed ID: 34990618
[TBL] [Abstract][Full Text] [Related]
20. MT1G Regulates c-MYC/P53 Signal to Inhibit Proliferation, Invasion and Migration and Promote Apoptosis in Colon Cancer Cells.
Li J; Hu Q; Li Z; Feng K; Li K
Curr Mol Med; 2024; 24(3):379-388. PubMed ID: 36999424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
